Business
Teva Pharmaceutical Industries Ltd. has agreed to pay $1.2 billion in a settlement with the U.S. Federal Trade Commission (FTC), resolving claims that Cephalon...
Hi, what are you looking for?
Teva Pharmaceutical Industries Ltd. has agreed to pay $1.2 billion in a settlement with the U.S. Federal Trade Commission (FTC), resolving claims that Cephalon...
Teva Pharmaceutical Industries Ltd, an Israeli-based company, has acquired a 1.35 percent stake in Mylan through purchases on the open market, increasing pressure on...
George Soros’ Soros Fund Management, which currently manages some $30 billion in assets, announced his holdings in filings with the Securities and Exchange Commission,...
Teva CFO Eyal Desheh told Merrill Lynch that it could secure antitrust clearance for the takeover in 4-7 months.
As Israeli pharmaceutical giant Teva pushes ahead with a $40-billion dollar hostile bid for US generic drugmaker Mylan, Brent Saunders, CEO of...
Deal to give Perrigo manufacturing technology for softgel products
Bloomberg reports Mylan chairman Robert Coury as telling investors he is prepared to reduce Perrigo shareholders' risk
Teva declined the chance because it does not operate in the store-brand OTC market, Perrigo's main activity.
Reuters Exclusive: Generics drugmaker Mylan NV (MYL.O), which is in the middle of a three-way takeover battle, has said it is unwilling to...
John Paulson's hedge fund has increased its holdings in Mylan NV to 4.5%.